News and Updates

Treatment resistant depression (TRD) is a subcategory of Major Depressive Disorder. There are various definitions but, broadly, it is a type of depression that does not respond to traditional therapies. It is quite common; in fact, a 2022 study found that up to 60 percent of psychiatric patients experience treatment resistance. Despite this number, alternative…

Bipolar disorder is a mental health disorder associated with extreme mood swings that can significantly impact quality of life. It also has a high rate of treatment resistance to current therapies. In this article, we will examine the potential for low dose ketamine as an alternative means of treating refractory bipolar disorder.  What is Bipolar…

The study of ketamine in the realm of mental health is ongoing. Early results are promising for many disorders, from PTSD to chronic pain and addiction. With demonstrated efficacy in even the most resistant cases, many individuals may be wondering about ketamine’s potential in the treatment of a particularly complicated area of mental health: personality…

Psychedelic drugs are being investigated for their therapeutic properties, particularly in the realm of mental health disorders. A version of psilocybin, for example, has been approved for human testing that is currently underway. However, as of this post, no psychedelic drugs have yet been approved by the FDA for the treatment of any disorders.This means…

In addition to growing support for its use in pain, depression, and anxiety, ketamine is now being studied as a potential aid in treating addiction. The drug, which has been FDA approved for treating refractory depression and acute suicidal ideation, has shown promising results in early clinical trials for substance abuse disorders.  Traditional Treatment for…